13G Filing: Partner Fund Management and Jounce Therapeutics Inc (JNCE)

Page 10 of 13

Page 10 of 13 – SEC Filing

CUSIP No. 481116101 13G Page
10 of 13 Pages
Item 4 Ownership
A. Partner Fund Management, L.P. and Partner Fund Management GP, LLC
(a) PFM and PFM-GP may be deemed to beneficially own 1,727,943 shares of Common Stock.
(b) The number of shares PFM and PFM-GP may be deemed to beneficially own constitutes approximately 5.4% of the Common Stock outstanding.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:  0
(ii) shared power to vote or to direct the vote:  1,727,943
(iii) sole power to dispose or to direct the disposition of:  0
(iv) shared power to dispose or to direct the disposition of:  1,727,943
B. Partner Investment Management, L.P. and Partner Investment Management GP, LLC
(a) PIM and PIM-GP may be deemed to beneficially own 14,265 shares of Common Stock.
(b) The number of shares PIM and PIM-GP may be deemed to beneficially own constitutes less than 0.1% of the Common Stock outstanding.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:  0
(ii) shared power to vote or to direct the vote:  14,265
(iii) sole power to dispose or to direct the disposition of:  0
(iv) shared power to dispose or to direct the disposition of:  14,265

Follow Jounce Therapeutics Inc.

Page 10 of 13